Generating New Cures
Summary
Artificial intelligence is transforming drug discovery and offering new hope against diseases that have long resisted treatment. As antibiotic resistance worsens, about 1.1 million people die each year from infections that were once easily treated, and the number could rise to over eight million deaths annually by 2050 if new solutions are not found. Scientists are therefore turning to AI to accelerate the search for medicines. Researchers such as James Collins have used machine learning to screen tens of millions of chemical compounds within days, identifying new antibiotic candidates capable of killing highly drug-resistant bacteria such as MRSA and gonorrhoea. AI is also being applied to complex illnesses like Parkinson's disease, where researchers have identified promising compounds that may slow the disease by targeting harmful protein clumps in the brain. Beyond creating new drugs, AI is helping scientists repurpose existing medicines for thousands of conditions, including rare diseases often overlooked by pharmaceutical companies.
Application
This development also illustrates an important distinction between augmentation and replacement in artificial intelligence. 1️⃣Replacement occurs when machines take over tasks entirely, removing the need for human involvement. 2️⃣Augmentation, however, refers to AI enhancing human capabilities rather than substituting them. In drug discovery, AI does not replace scientists. Instead, it dramatically expands their ability to explore possibilities. Researchers still formulate hypotheses, interpret results, and decide which compounds should proceed to laboratory testing. What AI contributes is speed and scale. It can analyse millions or even billions of chemical structures within days, something impossible for humans alone. In this way, AI functions as an intellectual amplifier that strengthens scientific investigation.